1. Home
  2. HIT vs NVNO Comparison

HIT vs NVNO Comparison

Compare HIT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIT
  • NVNO
  • Stock Information
  • Founded
  • HIT 1964
  • NVNO 1987
  • Country
  • HIT United States
  • NVNO United States
  • Employees
  • HIT N/A
  • NVNO N/A
  • Industry
  • HIT Specialty Insurers
  • NVNO Medical/Dental Instruments
  • Sector
  • HIT Finance
  • NVNO Health Care
  • Exchange
  • HIT Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • HIT 37.2M
  • NVNO 41.0M
  • IPO Year
  • HIT 2024
  • NVNO N/A
  • Fundamental
  • Price
  • HIT $0.72
  • NVNO $3.66
  • Analyst Decision
  • HIT
  • NVNO
  • Analyst Count
  • HIT 0
  • NVNO 0
  • Target Price
  • HIT N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • HIT 707.6K
  • NVNO 79.3K
  • Earning Date
  • HIT 04-14-2025
  • NVNO 05-01-2025
  • Dividend Yield
  • HIT N/A
  • NVNO N/A
  • EPS Growth
  • HIT N/A
  • NVNO N/A
  • EPS
  • HIT 0.02
  • NVNO N/A
  • Revenue
  • HIT $22,380,959.00
  • NVNO N/A
  • Revenue This Year
  • HIT $58.79
  • NVNO N/A
  • Revenue Next Year
  • HIT N/A
  • NVNO $409.09
  • P/E Ratio
  • HIT $48.91
  • NVNO N/A
  • Revenue Growth
  • HIT 11.24
  • NVNO N/A
  • 52 Week Low
  • HIT $0.51
  • NVNO $2.03
  • 52 Week High
  • HIT $7.59
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • HIT N/A
  • NVNO 66.24
  • Support Level
  • HIT N/A
  • NVNO $3.56
  • Resistance Level
  • HIT N/A
  • NVNO $3.97
  • Average True Range (ATR)
  • HIT 0.00
  • NVNO 0.23
  • MACD
  • HIT 0.00
  • NVNO 0.07
  • Stochastic Oscillator
  • HIT 0.00
  • NVNO 74.81

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: